Biomanufacturing revolutionizes the way we produce essential products, harnessing the power of biological systems to create a wide array of goods. At its core, biomanufacturing utilizes living organisms, such as bacteria, yeast, or mammalian cells, to produce pharmaceuticals, chemicals, food ingredients, and more. This innovative approach offers numerous advantages, including increased efficiency, sustainability, and flexibility in product design. In biopharmaceuticals, biomanufacturing plays a pivotal role in producing complex therapeutics like insulin, vaccines, and monoclonal antibodies. By leveraging genetically engineered microorganisms or cell cultures, manufacturers can produce large quantities of these lifesaving drugs with precision and consistency. Beyond pharmaceuticals, biomanufacturing extends its reach to sectors like agriculture and food production.
Engineered microorganisms can be employed to produce enzymes for food processing, bio-based chemicals for agricultural applications, and even alternative proteins to meet the growing demand for sustainable protein sources. One of the key benefits of biomanufacturing is its environmental sustainability. Unlike traditional manufacturing processes that rely heavily on fossil fuels and generate harmful byproducts, biomanufacturing often utilizes renewable resources and produces minimal waste, contributing to a greener, more sustainable future. Moreover, biomanufacturing offers unparalleled flexibility in product design. Through genetic engineering and synthetic biology techniques, researchers can tailor microorganisms to produce specific compounds or proteins with desired properties, opening doors to endless possibilities in product innovation.
Title : Application of vanadium and tantalum single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Valorizing lignocellulose to Ethylene Glycol: Catalysis, catalyst deactivation and conceptual process design
Jean Paul Lange, University of Twente, Netherlands
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Design of nanocomposite materials for active components of structured catalysts for biofuels transformation into syngas, catalytic layers of membrane reactors with oxygen/hydrogen separation and anodes of solid oxide fuels cells operating in the internal reforming mode
Vladislav Sadykov, Boreskov Institute of Catalysis, Russian Federation
Title : Human impact on natural environment and its implications
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-inspired & biotech-driven translational applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Solar heterogeneous photocatalysis and photochemistry for urban wastewater regeneration and reuse
Isabel Oller Alberola, Plataforma Solar de Almería, Spain
Title : Distal functionalization via transition metal catalysis
Haibo Ge, Texas Tech University, United States
Title : Effect of bed material on syngas quality: Comparison of biomass gasification with different bed materials
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Production of nanocomposites from wastes to remove the pollutants
Delia Teresa Sponza, Dokuz Eylul University, Turkey